Outsourcing of critical business activities – invoicing, delivery, warehousing and collections – is expected to accelerate twin-digit growth through efficient order processing and delivery and expanded physician reach.
Eskeen Laboratories, Inc. last month signed a three-year distribution agreement with Oxford Distributors, Inc. The partnership will allow Eskeen to focus on acquiring prescriptions in the competitive pediatric market. The move is expected to bring Eskeen to the Php 50M mark this year and Php 75M in 2022.
From left to right: Ina Reyes and Mando Salva, Oxford’s VP for Operations and General Managers, respectively; Emm Dapat, Jerry Paras and Jets Huerto, Eskeen’s Business Lead, Supply Chain Lead and Finance & Admin Lead, respectively.
As part of the partnership, Oxford Distributions, Inc. will handle the invoicing, warehousing, logistics and collections functions for Eskeen Laboratories. This means that Eskeen will be able to execute its customer acquisition strategy with increased reach and call frequency. This ultimately means higher quality customer contact with focus on product and commercial knowledge, customer-oriented communications, service quality, and overall territorial business performance.
Eskeen Laboratories, Inc. is a Filipino-owned dermatology specialty company engaged in R&D, sales and distribution of high quality and affordable solutions to a wide range of chronic and acute skin and aesthetic problems. It is very visible in therapeutic areas such as barrier repair and replenishment, acne, melasma, ageing skin, hair loss, sun protection, emollients and protectives and antifungals.
Oxford Distributions, Inc. has a long history and track record of delivering logistics and other services to the healthcare industry. It is a trailblazing organization in the field of pharmaceutical distribution fulfilling orders of drugstores, hospitals, government institutions and dispensing doctors with the entire gamut of products from those requiring cold chain handling (vaccines) to topical preparations.